Navigation Links
Supelco(R) and MIP Technologies Launch New SPE Product for the Selective Extraction of NSAIDs From Environmental Water
Date:7/16/2009

ST. LOUIS, July 16 /PRNewswire-FirstCall/ -- Supelco, a division of Sigma-Aldrich (Nasdaq: SIAL), and MIP Technologies AB announced today the launch of a new molecularly imprinted polymer, SPE product, SupelMIP(TM), for the selective extraction of non-steroidal anti-inflammatory drugs (NSAIDs).

"SupelMIP NSAIDS is an important addition to our portfolio because it targets a critical area of public concern - the increasing appearance of prescription and over-the-counter drugs in environmental water," said Anthony Rees, CEO of MIP Technologies. "This concern is reflected in the programs initiated by many governments to monitor national water resources for the presence and concentrations of the most frequently used drugs having the potential for adverse effects. This product recognizes members of the class of NSAIDs related to ibuprofen and will simplify the analysis of these drugs when present, at even low levels, in natural water samples."

SupelMIP was developed for confirmation and quantitation of NSAID drugs in water samples. The SPE phase has been developed for multi-residue extraction of NSAIDs and has been validated for ibuprofen, diclofenac, naproxen, clofibric acid, celecoxob and piroxicam.

"SupelMIP SPE allows researchers to selectively extract and recover non-steroidal anti-inflammatory drugs," said An Trinh, product manager of Sample Prep at Supelco. "Such compounds are among the most highly consumed pharmaceuticals in the world."

Ibuprofen, diclofenac and naproxen are non-steroidal anti-inflammatory drugs that have analgesic and antipyretic activities. Clofibric acid is an active metabolite of clofibrate, etofibrate and etofyllinclofibrate. These compounds are used as blood lipid regulators. Because of the pharmacological activity of the
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Supelco(R) Expands Ascentis(R) Express HPLC Columns Line for High-Speed and High-Efficiency Separations
2. Supelco(R) Introduces Ascentis(R) Express HILIC HPLC Columns for High-Speed and High-Efficiency Separations
3. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
4. Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
5. Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia
6. IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors
7. BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
8. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
9. Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show
10. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
11. Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ire-FirstCall/ -- Stallergenes has been,granted Eu...s and children,through a Mutual Recognition Proced...as been marketed, was the reference Member state. ..., Belgium, Bulgaria, Cyprus, the,Czech Republic, E... Italy,Latvia, Lithuania, Luxembourg, Malta, the ...
(Date:11/25/2009)...re/ -- Biotech firm Replikins Ltd., which has anal...ndemic through the prediction, outbreak, and progr... latest biochemical analysis of the virus. The new... Flu") virus has dropped from its peak of 3.7 (s.d...spring of 2009 to resting non-epidemic levels this...
(Date:11/25/2009)...Newswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a l...ed today that it executed,a joint venture (JV) agr...ology Co., Ltd. (Sinovac Dalian). The JV will rese... vaccines. Sinovac will contribute its expertise,a...rld-class vaccines; the,other party will bring its...
(Date:11/24/2009)...e-FirstCall/ -- IES (Nasdaq: IESC ), a leading na...ystems and services for the commercial, industrial... commercial business group has been awarded a cont...rical systems for the Level 4 bio-safety lab (BSL-...esearch Institute of Infectious Diseases (USAMRIID...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...9 The 2009 Frost & Sullivan European Drug Dis...nometrix AG in recognition of its active role in t...toxicity assays. , , (Logo: http://www.newscom...t kits, used in the early screening stages of drug...overy and development through lead optimisation. O...
...March 18 Nile Therapeutics, Inc. (Nasdaq: NLTX ...herapeutics for heart failure patients, today anno...50(b)(1)(B), its audited financial statements for ...in the Company,s Annual Report on Form 10-K, filed...ification from its independent registered public a...
...., March 18 Idenix Pharmaceuticals, Inc. (Nasdaq:...the discovery and development of drugs for the tre...at four abstracts from the company,s hepatitis C a...een accepted for presentation at the 44th Annual M...f the Liver (EASL, April 22-26, 2009 in Copenhagen...
Other Biology Technology:Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG 2Frost & Sullivan European Drug Discovery Product Innovation Award Bestowed on Xenometrix AG 3Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 2Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 3Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 2Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 3
(Date:11/25/2009)...e heart pumps some 250 million liters of blood thr... fibers of the heart have to be extremely durable....er, vice chair of the Department of Medicine III a...Dr. H. A. Katus), has discovered a protein that is...cular unit, the sarcomere. In cooperation with oth...
(Date:11/24/2009)...rs to understanding how sounds associated with Nav...l or if they hear it at all. , The same type of...ses to detect flaws in the space shuttle,s behemot... peek inside the giant head of a whale. The scans ...of a whale,s hearing anatomy using a breakthrough ...
(Date:11/24/2009)...r 24, 2009) -- The Wildlife Conservation Society (...ast remaining population of Siberian tigers has li... of poaching and habitat loss. , WCS...s of what needs to be done to protect remaining po... The report was released by the Siberian Tiger...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 1Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 2Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 3Reviews of microbial gene language published in special issue of Trends in Microbiology 9269 4CareFusion Prices 241 4 Billion of Senior Notes 51725 1CareFusion Prices 241 4 Billion of Senior Notes 51725 2Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 1Federal Judge Orders Schwarzenegger Administration to Comply with Order That Blocks State Reduction for IHSS Worker Wages 51721 2
...re examining a way of using bacteria to manufactur...are difficult to create synthetically on a lab ben...lly produce antibiotics called prodiginines. , ...nt interest as they can be used to target and kill...lled GX15-070 is currently in phase 1 and 2 cancer...
...r "crystal meth" while in the womb, reveals an ana... the Fetal and Neonatal Edition of Archives of Dis...ly used detection methods (blood and urine), canno...inguish among different drugs, say the authors. Bl...he chemical evidence it holds. , Crystal meth b...
...the eye cancer retinoblastoma than mice because, u...activity of a gene critical to normal retinal deve...tigators at St. Jude Children,s Research Hospital....rnal BMC Biology, explains why humans with a defec...gh risk of developing cancer of the retina, or ret...
Other Biology News:Hair samples show babies can be exposed to 'crystal meth' while in the womb 2
...me provides excellent background information, deta...dy of major HIV proteins including: the HIV growth...egrase and protease. Expression of HIV proteins us... assays; HIV/CD4 interactions; transient assays fo...
Sheep Anti-Mouse TREM-2 Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Ferret Whole Serum Polyclonal Antibody, Unconjugated from Bethyl Laboratories
...ers versatile liquid handling platforms and flexib... wide variety of life science applications.The Fre...es (75, 100, 150 and 200 cm), giving all laborator... with their application needs. Each platform can...
Biology Products: